Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
RADNOR, Pa., March 19, 2021 (GLOBE NEWSWIRE) -- NeuroRx, Inc. announced the first patient in its P2/3 study...
Letter from Seneca Biopharma's Executive Chairman PR Newswire GERMANTOWN, Md., Sept. 2, 2020 GERMANTOWN, Md., Sept. 2, 2020 /PRNewswire/...
Seneca Biopharma Announces the Closing of its $5 Million Registered Direct Offering PR Newswire GERMANTOWN, Md., May 27, 2020 GERMANTOWN, Md...
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _______________...
Seneca Biopharma to Begin Trading Under New Ticker Symbol SNCA PR Newswire GERMANTOWN, Md., Oct. 31, 2019 GERMANTOWN, Md., Oct. 31, 2019...
Seneca Biopharma and QYuns Therapeutics Sign Term Sheet for Global Licensing of Novel Monoclonal Antibodies for Treating Auto-Immune Diseases PR...
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM...
Seneca Biopharma to Present at the 7th China Renaissance Healthcare and Life Sciences Leadership Summit PR Newswire GERMANTOWN, Md., Oct. 28...
Neuralstem Becomes Seneca Biopharma PR Newswire GERMANTOWN, Md., Oct. 28, 2019 GERMANTOWN, Md., Oct. 28, 2019...
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지